{"id":"W4410692239","doi":"10.3390/curroncol32060296","title":"Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Health Authority; Saskatoon Medical Imaging; Saskatchewan Health; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Janssen Biotech","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Adverse effect; Incidence (geometry); Internal medicine; Oncology; Intensive care medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005586933,0.0002700803,0.0006244815,0.001607566,0.0000781366,0.00001498052,0.0002092712,0.0001535682,0.00005805494],"category_scores_gemma":[0.0001702092,0.0002342642,0.00005320533,0.001131578,0.0002012883,0.000107889,0.0002168171,0.000500633,0.0000252033],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2651184,"about_ca_system_score_gemma":0.056675,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2298603,"about_ca_topic_score_gemma":0.8219638,"domain_scores_codex":[0.9972727,0.0001482077,0.0005993719,0.0006015234,0.0003343725,0.001043829],"domain_scores_gemma":[0.9987607,0.0002772457,0.0001138762,0.0004083274,0.00008755211,0.0003523279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003031264,0.0001346721,0.9499127,0.0007108942,0.0000748064,0.0006028031,0.0002598168,0.0001815357,0.000001234645,0.0005630978,0.0008440082,0.04641127],"study_design_scores_gemma":[0.05025556,0.0006363735,0.9152319,0.00153157,0.0001011519,0.00001775332,0.0001956255,0.00873887,0.000008295308,0.0001182812,0.02291934,0.0002453127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855333,0.0006491996,0.00000782875,0.0003425666,0.0003703938,0.001636696,0.000009433737,0.00003348547,0.01141712],"genre_scores_gemma":[0.9974103,0.0004452068,0.0001215661,0.0002116976,0.00003621966,0.0002232506,0.00005364256,0.00002263097,0.001475475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5921034,"threshold_uncertainty_score":0.9553019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02196026998702834,"score_gpt":0.366915392494457,"score_spread":0.3449551225074287,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}